Conferences
APCCC 2024: Update on the IRONMAN Project
April 26, 2024
APCCC 2024: In Which Patients with Metachronous Low-volume mHSPC Do You Recommend “total Therapy”?
April 26, 2024
APCCC 2024: In Which Patients with Synchronous Low-Volume mHSPC Do You Recommend “Total Therapy”?
April 26, 2024
APCCC 2024: Radiation Therapy Schedules and Fields for High-Risk and Locally Advanced Prostate Cancer
April 26, 2024
APCCC 2024: Introduction to mHSPC – What Are Relevant Prognostic/Predictive Factors for the Management of Patients?
April 25, 2024
APCCC 2024: In Patients with BCR and Positive Lesion(s) in the Pelvis – Stereotactic or Whole Pelvis Radiotherapy?
April 25, 2024
APCCC 2024: How to Select Patients with Biochemical Relapse in Whom Salvage Radiation Therapy Can Be Postponed?
April 25, 2024
APCCC 2024: How to Manage Patients with PSA Persistence Following Radical Prostatectomy?
April 25, 2024